Clinical Trial Registration www. ClinicalTrials. gov, identifier: NCT04365634. Context
Diabetes mellitus was associated with increased severity and mortality of disease in COVID …

Background. COVID‐19 caused by severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) has threatened every civilian as a global pandemic. The immune system poses the …

The induction of inflammation and cytokine storm was proposed to play a critical role in
COVID‐19. This study is aimed at investigating the relationship between glucose …

Abstract Background Coronavirus disease 2019 (COVID-19) has been declared a global
pandemic. COVID-19 is more severe in people with diabetes. The identification of risk …

Abstract Background Coronavirus disease 2019 (COVID-19) is an emerging infectious
disease that first appeared in Wuhan, China, and quickly spread throughout the world. We …

People with diabetes have higher risks of various infections. Therefore, these diabetic
patients might be at increased risk of COVID‐19 and have a poorer prognosis. Up until now …

Objective. Coronavirus disease 2019 (COVID‐19) is a considerable global public health
threat. This study sought to investigate whether blood glucose (BG) levels or comorbid …

Aims To describe characteristics of COVID-19 patients with type 2 diabetes and to analyze
risk factors for severity. Methods Demographics, comorbidities, symptoms, laboratory …

Abstract Purpose Coronavirus disease 2019 (COVID-19) has become a topic of concern
worldwide; however, the impacts of type 2 diabetes mellitus (T2DM) on disease severity …

Abstract Aims Coronavirus disease (COVID-19), also referred to as severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is instigated by a novel coronavirus. The disease …